Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Amneal Pharmaceuticals
Lobbying Relationship
Bills mentioned
H.R.2212: CREATES Act of 2017
Sponsor: Tom Marino (R-Pa.)
S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.2051: FAST Generics Act of 2017
Sponsor: David McKinley (R-W.Va.)
H.R.749: Lower Drug Costs through Competition Act
Sponsor: Kurt Schrader (D-Ore.)
S.297: Increasing Competition in Pharmaceuticals Act
Sponsor: Susan Collins (R-Maine)
S.469: Affordable and Safe Prescription Drug Importation Act
Sponsor: Bernard Sanders (ID-Vt.)
H.R.2841: FAST Generics Act of 2015
Sponsor: Steve Stivers (R-Ohio)
S.3056: CREATES Act of 2016
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.34: 21st Century Cures Act
Sponsor: Suzanne Bonamici (D-Ore.)
H.R.4981: Opioid Use Disorder Treatment Expansion and Modernization Act
Sponsor: Larry Bucshon (R-Ind.)
H.R.4976: Opioid Review Modernization Act of 2016
Sponsor: Sean Patrick Maloney (D-N.Y.)
S.524: Comprehensive Addiction and Recovery Act of 2016
Sponsor: Sheldon Whitehouse (D-R.I.)
S.1137: PATENT Act
Sponsor: Charles E. Grassley (R-Iowa)
H.R.3762: To provide for reconciliation pursuant to section 2002 of the concurrent...
Sponsor: Tom Price (R-Ga.)
H.R.2029: Consolidated Appropriations Act, 2016
Sponsor: Charlie Dent (R-Pa.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.2725: Food and Drug Administration Safety Over Sequestration Act of 2013
Sponsor: Leonard Lance (R-N.J.)
H.R.1919: Safeguarding America's Pharmaceuticals Act of 2013
Sponsor: Robert E. Latta (R-Ohio)
H.R.3204: Drug Quality and Security Act
Sponsor: Fred Upton (R-Mich.)
S.1413: FDA User Fee Protection Act
Sponsor: Mark Pryor (D-Ark.)
S.959: Pharmaceutical Quality, Security, and Accountability Act
Sponsor: Tom Harkin (D-Iowa)
S.957: Drug Supply Chain Security Act
Sponsor: Michael Bennet (D-Colo.)
H.R.5311: CARA 2.0 Act of 2018
Sponsor: Marsha Blackburn (R-Tenn.)
S.2456: CARA 2.0 Act of 2018
Sponsor: Rob Portman (R-Ohio)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Christopher Bowlin | Hlth & Dom Policy Adv, Sen McCain, 09-Aug 13; HHS, 08-09 SPA, Sen John McCain (09-13) SPA, Sen. John McCain (09-13) |
| Lisa Layman | CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07) SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow (05-07) SPA, Sen. Stabenow (05-07) |
| Henry W Menn III | Min SD & Counsel, Cmte on Vet Affairs (04); CoS Sen Bob Graham (01-04); Sp Asst Leg Aff, FDA Off of Commiss(93-95) Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); |
| ROBERT FOREMAN | The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005) |
| Henry Menn III | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); Min SD & Counsel, Cmte on Vet Affairs (04) CoS, Sen. Bob Graham (01-04) CoS, Sen. Bob Graham (01 - 04) |
| Heny Menn III | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) |
| Chris Bowlin | Hlth & Dom Policy Adv, Sen McCain, 09-Aug 13; Asst Secr Legisl, HHS, 08-09; Dep Labor 01-02; Dep Asst Secr for Congr & Intgv Affairs |
| Henry Menn | CoS, Sen Bob Graham (01-04) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate